Status:
COMPLETED
Study in Patients With Asthma
Lead Sponsor:
Dey
Conditions:
Asthma
Eligibility:
All Genders
5-12 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.
Eligibility Criteria
Inclusion
- Children with a history of asthma
- Written guardian approval
Exclusion
- Current or recent asthma exacerbation, requiring hospitalization
- History of smoking
- Debilitating or systemic and/or life-threatening diseases.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00215410
End Date
October 1 2005
Last Update
November 11 2010
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Little Rock, Arkansas, United States, 72205
2
Research Site
Long Beach, California, United States, 90806
3
Research Site
Mission Viejo, California, United States, 92691
4
Research Site
Newport Beach, California, United States, 92660